Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study page now references revision v3.6.2 for the protocol/SAP, replacing the previous v3.6.0. This signals a newer version of the study documentation is available for review on the page.
    Difference
    0.0%
    Check dated 2026-06-27T02:17:19.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    New sections such as How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment have been added, while an older Intervention / Treatment heading was removed; the revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:17.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.5, replacing the previous v3.5.4, indicating a minor update to the study page.
    Difference
    0.0%
    Check dated 2026-06-05T10:18:53.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a new page revision tag: 'Revision: v3.5.4', and removed the previous tag 'Revision: v3.5.3'.
    Difference
    0.0%
    Check dated 2026-05-15T05:55:59.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page’s displayed revision/version label has been incremented from v3.5.2 to v3.5.3, reflecting a release/version update rather than changes to trial content.
    Difference
    0.0%
    Check dated 2026-04-24T05:51:48.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:09:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.